WASHINGTON — The VA has adopted aggressive goals and a new national structure to bring precision medicine to the 15,000 veterans diagnosed each year with prostate cancer.
NEW YORK — National guidelines recommend conservative management for men with low-risk prostate cancer, but concern about misclassification and other issues could lead patients and physicians to pursue treatment. Recent in diagnosis and monitoring at the VA could simplify the decision for veterans.
SEATTLE — The treatment options for prostate cancer are rapidly evolving, in no small part as a result of the VA’s expanded commitment to clinical trials and precision medicine.
RICHMOND, VA — A study on the VA’s pioneering use of quality metrics in radiation oncology for prostate cancer went into this month’s 2019 American Society for Radiation Oncology Annual Meeting in Chicago preselected as a “Best of ASTRO” presentation that will be presented around the world as a highlight of this year’s advances in radiation oncology.